Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:57:03.786Z.
Calculation as of: 2026-10-06T19:57:03.786Z.
Quote observation: 2026-10-06T19:53:37.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9eab42942c27d7457dfc33c45bb783e1a271ca5ab59202131f9efdd6250b8ad0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-03-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Healthcare Triangle, Inc.
Market Cap
$8.38M
EV/FCF Ratio
N/A
| NAME | MARKET CAP | EV/FCF RATIO |
|---|---|---|
| Healthcare Triangle, Inc. (HCTI) | $8.38M | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.12M | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.12M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.08M | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $8.93M | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.74M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2025-03-31 | 6.84x |
| 2025-03-28 | 7.24x |
| 2025-03-27 | 7.53x |
| 2025-03-26 | 7.61x |
| 2025-03-25 | 7.29x |
| 2025-03-24 | 7.69x |
| 2025-03-21 | 7.87x |
| 2025-03-20 | 7.76x |
| 2025-03-19 | 7.99x |
| 2025-03-18 | 8.11x |
| 2025-03-17 | 8.24x |
| 2025-03-14 | 8.95x |
| 2025-03-13 | 9.03x |
| 2025-03-12 | 8.52x |
| 2025-03-11 | 7.20x |
| 2025-03-10 | 6.99x |
| 2025-03-07 | 7.65x |
| 2025-03-06 | 7.79x |
| 2025-03-05 | 7.61x |
| 2025-03-04 | 7.49x |
| 2025-03-03 | 7.94x |
| 2025-02-28 | 8.90x |
| 2025-02-27 | 8.74x |
| 2025-02-26 | 9.80x |
| 2025-02-25 | 7.97x |
| 2025-02-24 | 7.36x |
| 2025-02-21 | 8.18x |
| 2025-02-20 | 9.70x |
| 2025-02-19 | 9.07x |
| 2025-02-18 | 12.74x |
| 2025-02-14 | 9.36x |
| 2025-02-13 | 10.84x |
| 2025-02-12 | 10.33x |
| 2025-02-11 | 10.75x |
| 2025-02-10 | 11.20x |
| 2025-02-07 | 11.48x |
| 2025-02-06 | 11.75x |
| 2025-02-05 | 12.67x |
| 2025-02-04 | 12.89x |
| 2025-02-03 | 12.63x |
| 2025-01-31 | 12.46x |
| 2025-01-30 | 13.52x |
| 2025-01-29 | 13.84x |
| 2025-01-28 | 13.42x |
| 2025-01-27 | 14.16x |
| 2025-01-24 | 13.80x |
| 2025-01-23 | 14.84x |
| 2025-01-22 | 15.06x |
| 2025-01-21 | 15.29x |
| 2025-01-17 | 16.08x |
| 2025-01-16 | 14.57x |
| 2025-01-15 | 14.61x |
| 2025-01-14 | 15.81x |
| 2025-01-13 | 16.05x |
| 2025-01-10 | 17.22x |
| 2025-01-08 | 17.92x |
| 2025-01-07 | 20.05x |
| 2025-01-06 | 26.42x |
| 2025-01-03 | 19.62x |
| 2025-01-02 | 15.13x |
| 2024-12-31 | 16.49x |
| 2024-12-30 | 14.25x |
| 2024-12-27 | 13.87x |
| 2024-12-26 | 13.24x |
| 2024-12-24 | 12.91x |
| 2024-12-23 | 13.56x |
| 2024-12-20 | 14.15x |
| 2024-12-19 | 14.22x |
| 2024-12-18 | 14.67x |
| 2024-12-17 | 15.03x |
| 2024-12-16 | 15.27x |
| 2024-12-13 | 15.27x |
| 2024-12-12 | 15.69x |
| 2024-12-11 | 14.66x |
| 2024-12-10 | 14.99x |
| 2024-12-09 | 15.98x |
| 2024-12-06 | 19.34x |
| 2024-12-05 | 12.35x |
| 2024-12-04 | 12.37x |
| 2024-12-03 | 11.36x |
| 2024-12-02 | 11.62x |
| 2024-11-29 | 12.38x |
| 2024-11-27 | 12.18x |
| 2024-11-26 | 14.29x |
| 2024-11-25 | 15.13x |
| 2024-11-22 | 18.06x |
| 2024-11-21 | 17.78x |
| 2024-11-20 | 18.91x |
| 2024-11-19 | 18.63x |
| 2024-11-18 | 18.77x |
| 2024-11-15 | 19.06x |
